Search research articles
Contact Us
Filters
Showing results (31-40 of 193) with videos related to
Page
of 20
Sort By:
Leukemia & Lymphoma
|
January 23, 2019
Bortezomib-based regimens in patients with POEMS syndrome: a case series in newly diagnosed and relapsed patients
Marcello Riva, Federica Lessi, Tamara Berno, et al.
Blood Advances
|
June 15, 2025
Peripheral neuropathy and BTKis in Waldenström: a response?
Chiara Briani, Bruno Ferrero, Alessandro Salvalaggio, et al.
European Journal of Neurology
|
February 24, 2026
Chronic Ataxic Neuropathy With Disialosyl Antibodies Responsive to Zanubrutinib
Benedetta Tierro, Andrea Visentin, Alessandro Salvalaggio, et al.
Current Oncology (Toronto, Ont.)
|
October 27, 2022
[18F]FDG PET/CT and PET/MR in Patients with Adrenal Lymphoma: A Systematic Review of Literature and a Collection of Cases
Laura Evangelista, Filippo Crimì, Andrea Visentin, et al.
Journal of Clinical Medicine
|
April 23, 2022
Old and New Drugs for Chronic Lymphocytic Leukemia: Lights and Shadows of Real-World Evidence
Monia Marchetti, Candida Vitale, Gian Matteo Rigolin, et al.
Hematological Oncology
|
October 9, 2020
Increase of immunoglobulin A during ibrutinib therapy reduces infection rate in chronic lymphocytic leukemia patients
Ramona Cassin, Andrea Visentin, Diana Giannarelli, et al.
Scientific Data
|
January 26, 2024
Extended-wavelength diffuse reflectance spectroscopy dataset of animal tissues for bone-related biomedical applications
Celina L Li, Carl J Fisher, Katarzyna Komolibus, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
April 15, 2020
The Bruton tyrosine kinase inhibitor ibrutinib improves anti-MAG antibody polyneuropathy
Francesca Castellani, Andrea Visentin, Marta Campagnolo, et al.
Journal of the Peripheral Nervous System : JPNS
|
December 18, 2018
Peripheral nervous system involvement in lymphomas
Chiara Briani, Andrea Visentin, Marta Campagnolo, et al.
Biomolecules
|
May 16, 2023
Is It Still Possible to Think about HSP70 as a Therapeutic Target in Onco-Hematological Diseases?
Nayla Mouawad, Guido Capasso, Edoardo Ruggeri, et al.
Page
of 20
Search research articles
Search
Showing results (31-40 of 193) with videos related to
Sort By:
Page
of 20
Leukemia & Lymphoma
|
January 23, 2019
Bortezomib-based regimens in patients with POEMS syndrome: a case series in newly diagnosed and relapsed patients
Marcello Riva, Federica Lessi, Tamara Berno, et al.
Blood Advances
|
June 15, 2025
Peripheral neuropathy and BTKis in Waldenström: a response?
Chiara Briani, Bruno Ferrero, Alessandro Salvalaggio, et al.
European Journal of Neurology
|
February 24, 2026
Chronic Ataxic Neuropathy With Disialosyl Antibodies Responsive to Zanubrutinib
Benedetta Tierro, Andrea Visentin, Alessandro Salvalaggio, et al.
Current Oncology (Toronto, Ont.)
|
October 27, 2022
[18F]FDG PET/CT and PET/MR in Patients with Adrenal Lymphoma: A Systematic Review of Literature and a Collection of Cases
Laura Evangelista, Filippo Crimì, Andrea Visentin, et al.
Journal of Clinical Medicine
|
April 23, 2022
Old and New Drugs for Chronic Lymphocytic Leukemia: Lights and Shadows of Real-World Evidence
Monia Marchetti, Candida Vitale, Gian Matteo Rigolin, et al.
Hematological Oncology
|
October 9, 2020
Increase of immunoglobulin A during ibrutinib therapy reduces infection rate in chronic lymphocytic leukemia patients
Ramona Cassin, Andrea Visentin, Diana Giannarelli, et al.
Scientific Data
|
January 26, 2024
Extended-wavelength diffuse reflectance spectroscopy dataset of animal tissues for bone-related biomedical applications
Celina L Li, Carl J Fisher, Katarzyna Komolibus, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
April 15, 2020
The Bruton tyrosine kinase inhibitor ibrutinib improves anti-MAG antibody polyneuropathy
Francesca Castellani, Andrea Visentin, Marta Campagnolo, et al.
Journal of the Peripheral Nervous System : JPNS
|
December 18, 2018
Peripheral nervous system involvement in lymphomas
Chiara Briani, Andrea Visentin, Marta Campagnolo, et al.
Biomolecules
|
May 16, 2023
Is It Still Possible to Think about HSP70 as a Therapeutic Target in Onco-Hematological Diseases?
Nayla Mouawad, Guido Capasso, Edoardo Ruggeri, et al.
Page
of 20